Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.